Age-related differences in the side effect profile of citalopram

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 27, Issue 3, 2003, Pages 545-548

  Barak, Yoram ^a   Swartz, Marnina ^a,b   Levy, Daniel ^a,b   Weizman, Ronit ^b,c  

^a ABARBANEL MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TEL AVIV COMMUNITY MENTAL HEALTH CENTER   (Israel)

Author keywords

Antidepressants; Autonomic side effects; Cardiovascular side effects; Citalopram; Depression; Serotonin

Indexed keywords

CITALOPRAM; PLACEBO;

ADULT; AGED; AGING; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NEUROPATHY; BRADYCARDIA; CARDIOVASCULAR SYMPTOM; CONTROLLED STUDY; DATA BASE; DEPRESSION; DIARRHEA; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; SEROTONINERGIC SYSTEM; SIDE EFFECT; SOMNOLENCE; STATISTICAL ANALYSIS; SWEATING; TACHYCARDIA; TREMOR; VERTIGO; XEROSTOMIA;

EID: 0037402942     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(03)00041-1     Document Type: Article

References (19)

1. Barbey J.T., Roose S.P. SSRI safety in overdose. J. Clin. Psychiatry. 59(Suppl. 15):1998;42-48.
2. Bazire S. Cardiovascular disease. Bazire S. Psychotropic Drug Directory. 2000;178-182 Mark Allen Publishing, Devon, UK.
3. Christensen P., Homsen H.Y., Pedersen O.L., Gram L.F., Kragh-Sorensen P. Orthostatic side effects of clomipramine and citalopram during treatment for depression. Psychopharmacology. 86:1985;383-385.
4. Glassman A.H., Bigger J.T. Cardiovascular effects of therapeutic doses of tricyclic antidepressants: a review. Arch. Gen. Psychiatry. 38:1981;815-820.
5. Grundemar L., Wohlfart B., Lagerstedt C., Bengtsson F., Eklundh G. Symptoms and signs of severe citalopram overdose. Lancet. 349:1997;1602.
6. Hyttel J. Citalopram - pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Progr. Neuro-Psychopharmacol. Biol. Psychiatry. 6:1982;277-295.
7. Janvier J.J., Peyraud-Waitzenegger M., Soulier P. Effects of serotonin on the cardio-circulatory system of the European eel (Anguilla anguilla) in vivo. J. Comp. Physiol. 166:1996;131-137.
8. 18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction. Brain Res. 813:1998;167-171.
9. Moller M., Thayssen P., Kragh-Sorensen P., Pedersen O.L., Kristensen C.B., Bjerre M., Benjaminsen S., Gram L.F. Mianserin: cardiovascular effects in elderly patients. Psychopharmacology. 80:1983;174-177.
10. Noble S., Benfield P. Citalopram. CNS Drugs. 8:1997;410-431.
11. Pacher P., Ungvari Z., Kecskemeti V., Furst S. Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants. Curr. Med. Chem. 5:1998;381-390.
12. Pacher P., Ungvari Z., Nanasi P.P., Furst S., Kecskemeti V. Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants and their cardiac effects. Is there any? Curr. Med. Chem. 6:1999;469-480.
13. Pacher P., Bagi Z., Lako-Futo Z., Ungvari Z., Nanasi P.P., Kecskemeti V. Cardiac electrophysiological effects of citalopram in guinea pig papillary muscle comparison with clomipramine. Gen. Pharmacol. 34:2000;17-23.
14. Personne M., Persson H., Sjoberg G. Citalopram toxicity. Lancet. 350:1997;518-519.
15. Rasmussen S.L., Overo K.F., Tanghoj P. Cardiac safety of citalopram: prospective trials and retrospective analyses. J. Clin. Psychopharmacol. 19:1999;407-415.
16. Saxena P.R., Villalon C.M. 5-Hydroxytryptamine: a chameleon in the heart. Trends Pharmacol. Sci. 12:1991;223-227.
17. Spigset O. Adverse reactions of selective serotonin reuptake inhibitors: report from a spontaneous reporting system. Drug Saf. 20:1999;277-287.
18. Thayssen P., Bjerre M., Kragh-Sorensen P., Moller M., Pedersen O.L., Kristensen C.B., Gram L.F. Cardiovascular effects of imipramine and nortriptyline in elderly patients. Psychopharmacology. 74:1981;360-364.
19. 123I]beta-CIT SPECT. Neurobiol. Aging. 21:2000;497-501.